Search research articles
Contact Us
Filters
Showing results (51-60 of 72) with videos related to
Page
of 8
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
June 1, 1986
L-654,284 a new potent and selective alpha 2-adrenoceptor antagonist
D J Pettibone, B V Clineschmidt, V J Lotti, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 1, 1987
Pharmacological profile of a new potent and specific alpha 2-adrenoceptor antagonist, L-657,743
D J Pettibone, B V Clineschmidt, V J Lotti, et al.
Journal of Medicinal Chemistry
|
June 1, 1978
Piperazinylpyrazines with central serotoninmimetic activity
W C Lumma, R D Hartman, W S Saari, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptide
M G Bock, R M DiPardo, P D Williams, et al.
Life Sciences
|
January 1, 1992
Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues
D J Pettibone, M T Kishel, C J Woyden, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1992
In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist
R S Chang, P K Siegl, B V Clineschmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1988
A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066
B V Clineschmidt, D J Pettibone, V J Lotti, et al.
Journal of Medicinal Chemistry
|
December 1, 1985
N-(1,3,4,6,7,12b-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin -2-yl)-N- methyl-2-hydroxyethane-sulfonamide: a potent and selective alpha 2-adrenoceptor antagonist
J R Huff, P S Anderson, J J Baldwin, et al.
Journal of Medicinal Chemistry
|
March 4, 1994
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor
P D Williams, P S Anderson, R G Ball, et al.
Journal of Medicinal Chemistry
|
December 1, 1984
Synthesis of 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, a new class of dopamine agonists
J H Jones, P S Anderson, J J Baldwin, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 72) with videos related to
Sort By:
Page
of 8
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
June 1, 1986
L-654,284 a new potent and selective alpha 2-adrenoceptor antagonist
D J Pettibone, B V Clineschmidt, V J Lotti, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 1, 1987
Pharmacological profile of a new potent and specific alpha 2-adrenoceptor antagonist, L-657,743
D J Pettibone, B V Clineschmidt, V J Lotti, et al.
Journal of Medicinal Chemistry
|
June 1, 1978
Piperazinylpyrazines with central serotoninmimetic activity
W C Lumma, R D Hartman, W S Saari, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptide
M G Bock, R M DiPardo, P D Williams, et al.
Life Sciences
|
January 1, 1992
Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues
D J Pettibone, M T Kishel, C J Woyden, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1992
In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist
R S Chang, P K Siegl, B V Clineschmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1988
A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066
B V Clineschmidt, D J Pettibone, V J Lotti, et al.
Journal of Medicinal Chemistry
|
December 1, 1985
N-(1,3,4,6,7,12b-hexahydro-2H-benzo[b]furo[2,3-a]quinolizin -2-yl)-N- methyl-2-hydroxyethane-sulfonamide: a potent and selective alpha 2-adrenoceptor antagonist
J R Huff, P S Anderson, J J Baldwin, et al.
Journal of Medicinal Chemistry
|
March 4, 1994
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor
P D Williams, P S Anderson, R G Ball, et al.
Journal of Medicinal Chemistry
|
December 1, 1984
Synthesis of 4-substituted 2H-naphth[1,2-b]-1,4-oxazines, a new class of dopamine agonists
J H Jones, P S Anderson, J J Baldwin, et al.
Page
of 8